Read more

January 10, 2022
2 min read
Save

Study investigates enablers, barriers of engagement with app-based home monitoring

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A study carried out at Moorfields Eye Hospital in London investigated enablers and barriers of engagement with app-based home monitoring of vision in patients with retinal diseases.

Perspective from Anat Loewenstein, MD

“The strongest predictor of uptake in our patient cohort was age, with older individuals relatively less likely to become active users, representing a risk factor for digital exclusion,” the authors wrote.

smartphone on table
Source: Adobe Stock

Better vision was positively associated with uptake and compliance.

The Home Vision Monitor app (HVM, Genentech) is an FDA-cleared, CE-marked self-test that uses shape discrimination hyperacuity to detect metamorphopsia in the central degrees of vision, according to the study. It is associated with a web-based review portal that automatically sends an alert message to the clinician if vision changes occur. Between May 2020 and February 2021, the app was offered to 417 patients treated with intravitreal injection who had a smartphone. They were asked to self-test twice a week.

The analysis of HVM data was integrated with an engagement survey to evaluate uptake, compliance and use rate and their association with patient characteristics. Uptake was defined as success in installing the app and using it at least once. Compliance was defined as regular use of the app for at least 4 weeks. Use rate was the total number of tests during the study period.

Two hundred fifty-eight patients (61.9%) were classified as active users, and 166 (64.3%) fulfilled the definition of compliance. Mean weekly app use was 1.83. Younger age, better vision and the number of injections at baseline were positively associated with uptake and compliance. Patients with age-related macular degeneration were more likely to be compliant than those with macular edema.

The survey, completed by 117 active users, showed a strong association between comfort with modern technologies and higher levels of app use rate. The expectation that closer vision monitoring could lead to improved eye health was the most common motivation to use the app.

Within the study, 26 alerts for vision worsening were triggered. In eight cases, changes were not subjectively perceived by the patients. Notification alerts demonstrated high sensitivity (84.6%) and specificity (88.5%).

Studies in controlled research environments have shown that the use of smartphone-based home monitoring apps can be beneficial for the management of patients with retinal diseases, according to the authors. However, “for real-world translation of such benefits to occur, potential barriers to adoption not manifested in controlled research environments require careful consideration,” they wrote.

Targeted interventions, such as educational initiatives aimed at increasing digital literacy, should be developed to address digital exclusion.

“As health care systems increasingly adopt digital and remote models of care, issues such as digital exclusion require careful consideration to both ensure equitable access and avert disparate outcomes,” the authors wrote.